Loading clinical trials...
Loading clinical trials...
A Phase 4, Open-label Study to Investigate the Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in the Treatment of Plaque Psoriasis Occurring in the Head and Neck Region
Conditions
Interventions
VTAMA (tapinarof) cream, 1%
Locations
10
United States
Dermavant Investigative Site
Macon, Georgia, United States
Dermavant Investigative Site
Chicago, Illinois, United States
Dermavant Investigative Sites
Rockville, Maryland, United States
Dermavant Investigative Site
Auburn Hills, Michigan, United States
Dermavant Investigative Site
Detroit, Michigan, United States
Dermavant Investigative Site
Las Vegas, Nevada, United States
Start Date
March 13, 2023
Primary Completion Date
June 30, 2023
Completion Date
July 19, 2023
Last Updated
June 12, 2025
NCT06857942
NCT06979453
NCT07449234
NCT07116967
NCT07250802
NCT07449702
Lead Sponsor
Organon and Co
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions